Original Paper
Neonatology 2012;101:40–46 Received: February 2, 2011
DOI: 10.1159/000327891 Accepted after revision: March 29, 2011
Published online: July 26, 2011
Risk Factors for Pulmonary Artery Hypertension
in Preterm Infants with Moderate or Severe
Bronchopulmonary Dysplasia
Do-Hyun Kim a Han-Suk Kim b Chang Won Choi b Ee-Kyung Kim b
Beyong Il Kim b Jung-Hwan Choi b
a Department of Pediatrics, Dongguk University Ilsan Hospital, G oyang , and b Department of Pediatrics,
Seoul National University College of Medicine, Seoul , Korea
Key Words cy ventilation, and hospitalization compared to those with-
Risk factor (cid:2) Pulmonary artery hypertension (cid:2) out PAH. Low 5-min Apgar scores ( ^ 6; relative risk (RR) 6.2;
Bronchopulmonary dysplasia 95% confidence interval (CI) 1.4–28.0; p = 0.017) and oligohy-
dramnios (RR 7.7; 95% CI 2.0–29.6; p = 0.030) were found to
be significant risk factors for PAH according to multivariate
Abstract analysis. C onclusions: The present study shows that oligo-
Background: Despite the potential importance of pulmo- hydramnios is a specific risk factor for PAH in preterm infants
nary artery hypertension (PAH) in preterm infants with bron- with moderate or severe BPD.
chopulmonary dysplasia (BPD), little is known about the risk Copyright © 2011 S. Karger AG, Basel
factors for PAH. Objectives: To investigate the risk factors for
PAH in preterm infants with BPD. M ethods: Infants diag-
nosed with BPD were assigned to the PAH group or non-PAH Introduction
group except for infants with mild BPD who had no PAH. PAH
was diagnosed on the basis of echocardiograms demon- The pathophysiology of bronchopulmonary dysplasia
strating elevated right ventricle pressure beyond the post- (BPD) has evolved from its classical form following the
natal age of 2 months. Logistic regression analysis was done introduction of antenatal glucocorticoid, surfactant re-
for the multivariate assessment of the risk factors for PAH in placement therapy, and gentler ventilatory support since
preterm infants with moderate or severe BPD. Results: A to- the disease condition was originally described by North-
tal of 98 infants among 145 infants with BPD were divided way in 1967 [ 1–4] . Recently, the impact of antenatal lung
into a PAH group (n = 25) or non-PAH group (n = 73), while injury and inflammatory response, and the mechanism
the remaining 47 infants had mild BPD with no PAH. Among underlying the priming effect of antenatal inflammation
the study patients, survival rate of the PAH group was sig- on the pathogenesis of current forms of BPD have been
nificantly lower than that of the non-PAH group. Infants with investigated [ 5, 6] . Despite this evolution, BPD still re-
PAH had more severe cases of BPD and underwent longer mains a major chronic pulmonary complication in small
durations of oxygen therapy, conventional or high-frequen- preterm infants [7] . Although most studies of BPD have
© 2011 S. Karger AG, Basel Han-Suk Kim, MD, PhD
1661–7800/12/1011–0040$38.00/0 Department of Pediatrics
Fax +41 61 306 12 34 Seoul National University Children’s Hospital
E-Mail karger@karger.ch Accessible online at: 28 Yongon-dong Chongno-gu, Seoul 110-744 (Korea)
www.karger.com www.karger.com/neo Tel. +82 2 2072 1696, E-Mail kimhans @ snu.ac.kr
Methods
Allpreterminfants<32weeks'gestation(n=295)
The study was approved by the institutional research ethics
•Jan.2005–Dec.2009
(cid:129)BorninSNUCHNICU committee at Seoul National University Hospital.
Patients
A retrospective review was performed of data from 295 infants
BPDinfants(n=145)
(cid:129)SurvivaltillPCA36weeks with a gestational age of ! 32 weeks born in the neonatal intensive
(cid:129)Nomajorcongenitalmalformations care unit (NICU) at Seoul National University Children’s Hospi-
tal during a 5-year period (January 2005 to December 2009). In-
fants with major congenital malformations (e.g. documented
MildBPD
Excluded(n=47) (noPAHinfants) chromosomal anomaly or multiple malformations) and infants
who died before reaching a postconceptional age (PCA) of 36
Analysis
weeks were excluded (n = 30). Infants diagnosed with BPD were
SevereormoderateBPD(n=98)
assigned to the PAH group or non-PAH group except for infants
PAH(n=25)
vs. with mild BPD who had no PAH. Data on the patients’ clinical
non-PAH(n=73) characteristics and outcomes were collected and analyzed retro-
spectively. A flow diagram showing the study design involving
the 295 infants enrolled in this study is presented in f igure 1 .
Clinical characteristics were evaluated by a single reviewer di-
Fig. 1. Flow diagram showing the study design of the 145 infants
rectly from medical records. Clinical characteristics studied in-
with BPD and PAH enrolled in this study. SNUCH = Seoul Na-
cluded birth weights ! 3rd percentile for age, preterm premature
tional University Children’s Hospital.
rupture of membrane (PPROM, rupture of membranes before 37
completed weeks of gestation and 24 h prior to delivery), histo-
logic chorioamnionitis (HCAM, presence of acute inflammatory
changes on examination found up on a membrane roll and the
placental chorionic plate), prenatal steroids (any dose of steroids
focused primarily on airway pathologies, infants with
including either a partial or completed course), and oligohydram-
BPD are also at high risk of cardiovascular sequelae such nios (defined as amniotic fluid index ! 5 cm by ultrasound per-
as pulmonary artery hypertension (PAH), left ventricular formed just before delivery [ 16] ).
hypertrophy, systemic hypertension, systemic to pulmo- BPD and its severity were defined using the criteria of the Na-
nary collateral vessels, and others [ 8] . tional Institute of Child Health Workshop definition for BPD [ 17] ,
i.e. treatment with oxygen for at least 28 days with division into
Early injury to the lung circulation leads to the rapid
the following three subgroups at 36 weeks’ PCA: (1) mild (breath-
development of PAH after premature birth [ 8] . According ing room air); (2) moderate (need for a ! 30% fraction of inspired
to several small studies concerning the outcomes of in- oxygen (FiO )), and (3) severe (need for 6 30% fraction of inspired
2
fants with PAH and BPD, a quarter of BPD infants later oxygen and/or positive pressure support). A diagnosis of respira-
show echocardiographic evidence of PAH [9, 10] . Al- tory distress syndrome (RDS) required the presence of respira-
tory distress, increased oxygen requirement and a radiological
though the exact mechanisms responsible for pulmonary
finding consistent with RDS in the absence of evidence of any
vascular resistance remain incompletely understood,
other cause of respiratory distress. Intraventricular hemorrhage
PAH in BPD results from increased vascular tone and ab- (IVH) and necrotizing enterocolitis (NEC) were classified using
normal vasoreactivity, hypertensive remodeling, and de- the Volpe grading system and modified Bell’s staging criteria, re-
creased vascular growth [8, 11] . The development of PAH spectively [18, 19] . Presence of proven sepsis was defined as at least
a single blood culture and clinical signs of infection. Patent ductus
is sometimes a serious complication of BPD that can sig-
arteriosus (PDA) was diagnosed by echocardiography.
nificantly impact the morbidity and mortality rates of
preterm infants [12–14] . Pulmonary Artery Hypertension
Currently, there are few published studies about the In the cardiologic division of Seoul National University Chil-
clinical course and outcomes of PAH in preterm infants dren’s Hospital, we conducted monthly echocardiographic exam-
ination of the preterm infants with BPD in the NICU to screen for
with BPD [ 15] . Despite the potential importance of PAH
PAH and of the follow-up patients with moderate to severe BPD
in preterm infants, little is also known about the risk fac-
after discharge from the hospital even though the patients did not
tors for PAH in preterm infants with BPD. A lack of in- have PAH while in the NICU. PAH was diagnosed on the basis of
formation about the risk factors for PAH complicates de- echocardiograms demonstrating elevated right ventricle (RV)
velopment of appropriate screening guidelines for PAH pressure using the following criteria: (1) velocity of tricuspid valve
regurgitation of 6 3 m/s in the absence of pulmonary stenosis,
in preterm infants with BPD. The objective of this study
and (2) flat or leftward deviated interventricular septal configura-
was to investigate the risk factors for PAH in preterm in-
tion, and right ventricular hypertrophy with chamber dilation.
fants with BPD in the postsurfactant era. Patients with one or both of these findings beyond 2 months of
Risk Factors for PAH with BPD Neonatology 2012;101:40–46 41
age were characterized as having PAH. Patients with PAH that Except for 47 infants with mild BPD that had no PAH
persisted beyond 2 months of age with echocardiographic evi- among these 145 infants, a total of 98 infants were divid-
dence of PAH before 2 months of age were included in this study.
ed into the PAH group (n = 25) or non-PAH group (n =
Patients with congenital heart disease (except those with a patent
73) ( table 1 ).
foramen ovale, PDA, or atrial septal defect), persistent pulmonary
hypertension of the newborn, or congenital diaphragmatic hernia In all subjects, infants with PAH had a greater need for
were excluded. 6 30% FiO or positive pressure support at PCA 36 weeks,
2
suggesting severe BPD (p = 0.000) and longer durations
Data Analyses
of oxygen therapy (p = 0.011), conventional or high-fre-
To investigate the impact of PAH on the outcomes of preterm
quency ventilation (p = 0.032), and hospitalization (p =
infants with BPD, we performed univariate analyses for the fol-
lowing variables: durations of oxygen therapy, conventional or 0.022) compared to those without PAH (t able 1 ). Five pa-
high-frequency ventilation, and hospitalization, weight ! 3rd per- tients (20%) in the PAH group died during the follow-up
centile for age at discharge, and expired patients after PCA 36 period in contrast with 1 patient (1%) in the non-PAH
weeks.
group who died. Among with all subjects, the average
Next, in an attempt to define the roles of different risk factors
survival rate of the PAH group was significantly lower
associated with the development of PAH in preterm infants with
BPD, we performed univariate analyses to compare the following than that of the non-PAH group (p = 0.011) ( fig. 2 ).
variables which are presumed to be associated with the develop- Univariate analysis for the comparison of clinical
ment of PAH in infants with or without PAH as reported in previ-
characteristics according to the presence or absence of
ous studies [ 11, 15, 20] : gender, multiple births, mode of delivery,
PAH in all subjects included in this study showed a sta-
gestational age, birth weight, birth weight ! 3rd percentile for age,
low 5-min Apgar scores ( ^ 6), PPROM, HCAM, prenatal steroids tistically significant difference (p ! 0.05) in three vari-
administration, preeclampsia, oligohydramnios, RDS, PDA, IVH ables ( table 1 ): birth weight ! 3rd percentile for age (28 vs.
(Gr 6 3), NEC (stage 6 2), and proven sepsis. The univariate anal- 10%, p = 0.031), low 5-min Apgar scores (^ 6; 88 vs. 63%,
yses were followed by a multivariate logistic regression analysis to
p = 0.015), and oligohydramnios (40 vs. 8%, p = 0.001).
determine independent risk factors for the development of PAH.
We investigated the specific risk factors for the develop-
Variables that were significant in the previous univariate analyses
ment of PAH by multivariate logistic regression analysis
were chosen to be included in the logistic regression model. For
this analysis, we used the binary logistic regression procedure. with adjustment for variables which were significant in
Using this analytic method, we evaluated the contribution of each the previous univariate analysis. In all subjects, low 5-min
variable to the logistic regression model and selected the ones Apgar scores (^ 6; RR 6.2; 95% CI 1.4–28.0; p = 0.017) and
whose contribution was significant independent of the effect of
oligohydramnios (RR 7.7; 95% CI 2.0–29.6; p = 0.030)
the other variables in the model. Next, we calculated the adjusted
were found to be significant risk factors for PAH after ad-
relative risks (RR) for the development of PAH and the 95% con-
fidence intervals (CI) of the selected variables. justing for birth weight ! 3rd percentile for age, low 5-min
Statistical analyses were performed using SPSS for Windows, Apgar scores (^ 6), and oligohydramnios ( table 2 ). Uni-
version 12.0 (SPSS Inc., Chicago, Ill., USA). Categorical variables
variate analysis in a total of 40 infants with severe BPD
were analyzed by the (cid:2) 2 test and Fisher’s exact test. Differences in
showed a statistically significant difference in two vari-
continuous variables were assessed by Student’s t test and the
ables: low 5-min Apgar scores (^ 6) and oligohydramni-
Mann-Whitney U test. Time-dependent outcomes were assessed
using Kaplan-Meier analysis, with comparison between two os. In addition, in the multivariate analysis, low 5-min
groups using the log-rank test. Data are presented as mean 8 SD Apgar scores (^ 6; RR 7.8; 95% CI 1.2–52.0; p = 0.034) and
or frequency. p values ! 0.05 were considered significant.
oligohydramnios (RR 7.2; 95% CI 1.1–47.3; p = 0.040)
were also significant risk factors for PAH after adjusting
for low 5-min Apgar scores (^ 6) and oligohydramnios.
Results
Of the 295 infants enrolled in the present study, 145 Discussion
(49%) were diagnosed as having BPD. A total of 25 pre-
term infants (17 males and 8 females) with BPD had PAH. In the present study, most of the infants diagnosed as
PAH was diagnosed in 52.5% (21/40) of infants with se- having PAH had underlying severe BPD (84%, 21/25) and
vere BPD, 6.9% (4/58) of infants with moderate BPD, and none of them had underlying mild BPD. This proportion
0% (0/47) of infants with mild BPD. Risk for the develop- of infants with underlying severe BPD among ones diag-
ment of PAH in infants with severe BPD was 7.6 times nosed as having PAH was much higher than the 41% re-
higher than those with moderate BPD (p = 0.000). PAH ported in a recent study [ 15] . We excluded infants with
was diagnosed at a median age of 90 days (range 33–250). mild BPD from our study because the inclusion of infants
42 Neonatology 2012;101:40–46 Kim /Kim /Choi /Kim /Kim /Choi
Table 1. Univariate analysis of clinical characteristics according to the presence or absence of PAH in all subjects of this study
Clinical characteristics All study patients PAH Non-PAH p
(n = 98) (n = 25) (n = 73) values
Male 61 (62) 17 (68) 44 (60) NS
Multiple births 51 (52) 8 (32) 40 (55) NS
Cesarean section 68 (69) 19 (76) 49 (67) NS
Gestational age, weeks 26.881.9 26.982.4 26.481.9 NS
Birth weight, g 8358228 7658237 7998234 NS
Birth weight <3rd percentile for age 14 (14) 7 (28) 7 (10) 0.031
5-min Apgar scores, ≤6 68 (69) 22 (88) 46 (63) 0.015
PPROM 43 (44) 13 (52) 30 (41) NS
HCAM 29 (30) 5 (20) 24 (33) NS
Prenatal steroids administration 70 (71) 16 (64) 54 (74) NS
Preeclampsia 16 (16) 7 (28) 9 (12) NS
Oligohydramnios 16 (16) 10 (40) 6 (8) 0.001
RDS 58 (59) 15 (60) 43 (59) NS
PDA 93(95) 23 (92) 70 (96) NS
IVH, Gr ≥3 14 (14) 4 (16) 10 (14) NS
NEC, stage ≥2 13 (13) 4 (16) 9 (12) NS
Proven sepsis 32 (33) 9 (36) 23 (32) NS
Need for ≥30% FiO or positive
2
pressure support at PCA 36 weeks 40 (41) 21 (84) 19 (26) 0.000
Duration of O therapy, days 106852.8 141884.3 93.5828.4 0.011
2
Duration of CV or HFV, days 50.8855.6 82.5892.3 39.9829.2 0.032
Duration of hospitalization, days 116852.1 147883.5 105.5829.8 0.022
Weight <3rd percentile for age at discharge 51/92 (55) 13/20 (65) 38/72 (53) NS
Expired after PCA 36 weeks 6 (6) 5 (20) 1 (1) 0.004
V alues are expressed as mean 8 SD or numbers of individuals tory distress syndrome; PDA = patent ductus arteriosus; IVH =
with percentages in parentheses. intraventricular hemorrhage; NEC = necrotizing enterocolitis;
p values: PAH group vs. non-PAH group. FiO = fraction of inspired oxygen; PCA = postconceptional age;
2
NS = Not significant; PPROM = preterm premature rupture of CV = conventional ventilation; HFV = high-frequency ventila-
membrane; HCAM = histologic chorioamnionitis; RDS = respira- tion.
with mild BPD having no PAH could make it difficult to conventional or high-frequency ventilation, and hospi-
identify the risk factors for PAH. talization than those without PAH, PAH may be a serious
It has been reported that the mortality rate for PAH factor impacting the outcomes of BPD.
among preterm infants with BPD is very high. Two stud- Recent experimental studies have shown that early in-
ies published in the ‘presurfactant era’ showed mortality jury to the developing lung can impair angiogenesis
rates of 50 and 29%, respectively, in infants with BPD and which further contributes to decreased alveolarization
PAH [ 12, 13] . Additionally, in the ‘postsurfactant era’, and simplification of distal lung airspace, leading to the
PAH with BPD was strongly associated with poor sur- development of BPD (the ‘vascular hypothesis’) [21–23] .
vival with a recent report showing a mortality rate of 38% It is also speculated that reciprocal interactions exist be-
for infants with PAH [ 15] . Contrary to our study, all of the tween the developing airspace and pulmonary circula-
reports mentioned above did not compare the mortality tion [ 24] . Abnormal lung circulation in BPD patients, in-
rates of infants with PAH to non-PAH patients. In the cluding both anatomical and physiologic abnormalities,
present study, a mortality rate of 20% associated with is related to the development of PAH. Patients with BPD
PAH was significantly higher than the 1% observed in show a reduction of small pulmonary arteries and an al-
infants without PAH but with moderate or severe BPD. tered distribution of pulmonary arteries within the pul-
In addition, given that infants with PAH have more se- monary interstitium that cause reduction of the alveolar-
vere cases of BPD and longer durations of oxygen therapy, capillary surface area [ 2, 25] . This reduction in surface
Risk Factors for PAH with BPD Neonatology 2012;101:40–46 43
Table 2. Risk factors for the development of PAH in each group determined by binary logistic regression anal-
ysis
Clinical characteristics Unadjusted RR p Adjusted1 RR p
(95% CI) values (95% CI) values
Birth weight <3rd percentile for age 2.9 (1.1–7.5) 0.031 3.0 (0.1–1.9) 0.282
5-min Apgar scores, ≤6 1.4 (1.1–1.8) 0.015 6.2 (1.4–28.0) 0.017
Oligohydramnios 4.9 (2.0–12.0) 0.001 7.7 (2.0–29.6) 0.030
1 Adjusted for birth weight <3rd percentile for age, 5-min Apgar scores (≤6), and oligohydramnios in all
subjects included in this study.
PAH in all subjects with moderate or severe BPD. To
identify the risk factors for PAH with BPD regardless of
73 Non-PAH
1.0 its severity, we performed additional analyses on the sub-
25 72
jects with severe BPD but not those with moderate BPD.
In these analyses, 5-min Apgar scores ( ^ 6) and oligohy-
22
dramnios were also significant independent risk factors
0.8
20 PAH for PAH. The notable finding of the present study is that
oligohydramnios was the specific risk factor for PAH in
al preterm infants with BPD. Oligohydramnios is likely to
v
urvi 0.6 log-ranktest:0.011
influence growth and morphogenesis of the developing
s
of lung. Furthermore, a retrospective study conducted in
bility infants with a gestational age of ! 37 weeks who had an
ba 0.4 echocardiographic diagnosis of PAH within the first 4
o
Pr weeks of life also suggested that oligohydramnios was in-
dependently predictive of PAH [ 20] . Normal transition
from the canalicular stage to the saccular stage of devel-
0.2
opment requires the production of fluid by the fetal lung.
Lung fluid is kept pressurized by a combination of laryn-
geal closure and fluid production by the respiratory epi-
0 thelia. The pressure of fetal lung fluid is important for
0 5 10 15 20 25 lung growth as illustrated by the pulmonary hypoplasia
Monthsafterbirth
seen in neonates with oligohydramnios [26–28] . Preterm
infants with hypoplastic lungs may have elevated pulmo-
Fig. 2. Kaplan-Meier curve demonstrating the probability of sur- nary vascular resistance; this may be related to maldevel-
vival from the time of birth for the study patients with moderate opment including a decrease in the cross-sectional area
or severe BPD (n = 98), including infants with PAH (n = 25) and
and abnormal muscularization of the pulmonary vascu-
those without PAH (n = 73). Survival rate of the PAH group was
lature [ 28–30] . Although there was no evidence of defi-
significantly lower than that of the non-PAH group (p = 0.011).
The numbers of infants that survived are indicated along the re- nite hypoplastic lungs in infants according to our study,
spective curves. some inhibitive effect of oligohydramnios on lung devel-
opment might influence the development of PAH in pre-
term infants with BPD. Altogether, our results suggest
that oligohydramnios may contribute to vascular arrest
area leads to impaired gas exchange and increases the re- as well as alveolar arrest during fetal lung development,
quirement for prolonged oxygen and ventilator treatment and furthermore result in the subsequent development of
which in turn raises the risk of severe PAH [ 11] . In the PAH in BPD patients. This corresponds to the ‘vascular
present study, low 5-min Apgar scores (^ 6) and oligohy- hypothesis’ of BPD. In the present study, a low 5-min Ap-
dramnios were significant independent risk factors for gar score (^ 6) was another specific risk factor for PAH in
44 Neonatology 2012;101:40–46 Kim /Kim /Choi /Kim /Kim /Choi
preterm infants with BPD. Some researchers reported In summary, among infants with moderate or severe
that oligohydramnios is associated with an increased risk BPD, the survival rate of ones with PAH was significant-
of adverse perinatal outcome [31, 32] . In one meta-analy- ly lower than that of infants who did not. Furthermore,
sis, infants with oligohydramnios had a 5.2-fold increased the infants with PAH had to undergo longer durations of
risk for a 5-min Apgar score of ! 7 [31] . Based on these oxygen therapy, conventional or high-frequency ventila-
previous studies, it is assumed that low 5-min Apgar tion, and hospitalization than those without PAH. Oligo-
scores (^ 6) found to be a PAH risk factor can be the con- hydramnios was a specific risk factor for PAH in preterm
sequence of oligohydramnios. Meanwhile, Khemani et infants with moderate or severe BPD. We therefore sug-
al. [ 15] reported that among 18 patients with severe PAH gest that a more active screening echocardiogram may be
(systemic or supra-systemic RV pressure) almost half needed for diagnosing PAH in preterm infants with mod-
were born with weight ! 3rd percentile for age, which sug- erate or severe BPD, especially in the setting of oligohy-
gests that birth weight ! 3rd percentile for age may be at dramnios. Further large cohort studies will be required
increased risk for severe PAH. This same group [ 15] also to confirm our results and identify other risk factors for
reported that birth weight ! 3rd percentile for age with the development of PAH in infants with BPD.
severe PAH is associated with worse survival rates in
multivariate analyses, However, in the present study birth
weight ! 3rd percentile for age was associated with the Acknowledgments
development of PAH in the univariate analysis but not in
The authors would like to thank Professors Gi Beom Kim, Eun
the multivariate analysis.
Jung Bae, and Chung Il Noh at the Department of Pediatrics in
In the present study, the diagnosis of PAH depended
Seoul National University Children’s Hospital for their kind as-
entirely on echocardiography. Cardiac catheterization sistance and advice. This study was supported by a KT&G Grant-
has been accepted as the gold standard for diagnosing in-Aid for neonatal research (SNUCH 20060101, 20080101) and
PAH to date. However, since this procedure is very inva- by a grant from the Research & Development Project of Korea
Health Industry Development Institute, Ministry of Health &
sive and is not easily performed in the preterm cases in
Welfare, Republic of Korea (A080588-1021-1260200).
NICU, serial echocardiography is recommended as the
main tool to screen for PAH in BPD patients despite its
several limitations [ 11, 33] . In the present study, it was
Disclosure Statement
found that echocardiography is a useful tool for diagnos-
ing PAH and predicting the outcomes in infants with The authors have no conflicts of interest to disclose.
BPD in clinical setting.
References
1 Northway WH Jr, Rosan RC, Porter DY: Pul- 5 Kim DH, Kim HS, Shim SY, Lee JA, Choi 9 Fitzgerald D, Evans N, Van Asperen P, Hen-
monary disease following respirator therapy CW, Kim EK, Kim BI, Choi JH: Cord blood derson-Smart D: Subclinical persisting pul-
of hyaline-membrane disease: bronchopul- KL-6, a specific lung injury marker, corre- monary hypertension in chronic neonatal
monary dysplasia. N Engl J Med 1967; 276: lates with the subsequent development and lung disease. Arch Dis Child Fetal Neonatal
357–368. severity of atypical bronchopulmonary dys- Ed 1994; 70:F118–F122.
2 Hussain NA, Siddiqui NH, Stocker JT: Pa- plasia. Neonatology 2008; 93: 223–229. 10 Subhedar NV, Shaw NJ: Changes in pulmo-
thology of arrested acinar development in 6 Kim DH, Choi CW, Kim EK, Kim HS, Kim nary arterial pressure in preterm infants
postsurfactant bronchopulmonary dyspla- BI, Choi JH, Lee MJ, Yang EG: Increased pul- with chronic lung disease. Arch Dis Child
sia. Hum Pathol 1998; 29: 710–717. monary interleukin-6 with the priming ef- Fetal Neonatal Ed 2000; 82:F243–F247.
3 Bancalari E, Claure N, Sosenko IR: Broncho- fect of intra-amniotic lipopolysaccharide on 11 Mourani PM, Mullen M, Abman SH: Pulmo-
pulmonary dysplasia: changes in pathogen- hyperoxic lung injury in a rat model of bron- nary hypertension in bronchopulmonary
esis, epidemiology and definition. Semin chopulmonary dysplasia. Neonatology 2010; dysplasia. Pediatr Cardiol 2009; 27: 43–48.
Neonatol 2003; 8: 63–71. 98: 23–32. 12 Fouron JC, Le Guennec JC, Villemant D,
4 Speer CP: Chorioamnionitis, postnatal fac- 7 Greenough A: Long-term pulmonary out- Perreault G, Davignon A: Value of echocar-
tors and proinflammatory response in the come in the preterm infant. Neonatology diography in assessing the outcome of bron-
pathogenetic sequence of bronchopulmona- 2008; 93: 324–327. chopulmonary dysplasia of the newborn. Pe-
ry dysplasia. Neonatology 2009; 95: 353–361. 8 Abman SH: Monitoring cardiovascular diatrics 1980; 65: 529–535.
function in infants with chronic lung disease
of prematurity. Arch Dis Child Fetal Neona-
tal Ed 2002; 87:F15–F18.
Risk Factors for PAH with BPD Neonatology 2012;101:40–46 45
13 Goodman G, Perkin RM, Anas NG, Sperling 20 Kumar VH, Hutchison AA, Lakshmin- 27 Kilbride HW, Yeast J, Thibeault DW: Intra-
DR, Hicks DA, Rowen M: Pulmonary hyper- rusimha S, Morin FC III, Wynn RJ, Ryan partum and delivery room management of
tension in infants with bronchopulmonary RM: Characteristics of pulmonary hyper- premature rupture of membranes compli-
dysplasia. J Pediatr 1988; 112: 67–72. tension in preterm neonates. J Perinatol cated by oligohydramnios. Clin Perinatol
14 Bush A, Busst CM, Knight WB, Hislop AA, 2007; 27: 214–219. 1989; 16: 863–888.
Haworth SG, Shinebourne EA: Changes in 21 Abman SH: Bronchopulmonary dysplasia: a 28 Geary C, Whitsett J: Inhaled nitric oxide for
pulmonary circulation in severe broncho- vascular hypothesis. Am J Respir Crit Care oligohydramnios-induced pulmonary hy-
pulmonary dysplasia. Arch Dis Child 1990; Med 2001; 164: 1755–1756. poplasia: a report of two cases and review of
65: 739–745. 22 Bhatt AJ, Pryhuber GS, Huyck H, Watkins the literature. J Perinatol 2002; 22: 82–85.
15 Khemani E, McElhinney DB, Rhein L, An- RH, Metlay LA, Maniscalco WM: Disrupted 29 Kilbride HW, Thibeault DW: Neonatal com-
drade O, Lacro RV, Thomas KC, Mullen MP: pulmonary vasculature and decreased vas- plications of preterm premature rupture of
Pulmonary artery hypertension in formerly cular endothelial growth factor, Flt-1, and membranes. Pathophysiology and manage-
premature infants with bronchopulmonary TIE-2 in human infants dying with broncho- ment. Clin Perinatol 2001; 28: 761–785.
dysplasia: clinical features and outcomes pulmonary dysplasia. Am J Respir Crit Care 30 Kabra NS, Kluckow MR, Powell J: Nitric ox-
in the surfactant era. Pediatrics 2007; 120: Med 2001; 164: 1971–1980. ide in preterm infant with pulmonary hypo-
1260–1269. 23 Lassus P, Turanlahti M, Heikkilä P, Anders- plasia. Indian J Pediatr 2004; 71: 427–429.
16 Moore TR, Cayle JE: The amniotic fluid in- son LC, Nupponen I, Sarnesto A, Andersson 31 Chauhan SP, Sanderson M, Hendrix NW,
dex in normal human pregnancy. Am J Ob- S: Pulmonary vascular endothelial growth Magann EF, Devoe LD: Perinatal outcome
stet Gynecol 1990; 162: 1168–1173. factor and Flt-1 in fetuses, in acute and and amniotic fluid index in the antepartum
17 Jobe AH, Bancalari E: Bronchopulmonary chronic lung disease, and in persistent pul- and intrapartum periods: a meta-analysis.
dysplasia. NICHD-NHLBI-ORD Workshop. monary hypertension of the newborn. Am J Am J Obstet Gynecol 1999; 181: 1473–1478.
Am J Respir Crit Care Med 2001; 163: 1723– Respir Crit Care Med 2001; 164: 1981–1987. 32 Casey BM, McIntire DD, Bloom SL, Lucas
1729. 24 Parker TA, Abman SH: The pulmonary cir- MJ, Santos R, Twickler DM, Ramus RM, Le-
18 Volpe JJ: Intracranial hemorrhage: germinal culation in bronchopulmonary dysplasia. veno KJ: Pregnancy outcomes after ante-
matrix-intraventricular hemorrhage; in Vol- Semin Neonatol 2003; 8: 51–62. partum diagnosis of oligohydramnios at
pe JJ (ed): Neurology of the Newborn. Phila- 25 De Paepe ME, Mao Q, Powell J, Rubin SE, or beyond 34 weeks’ gestation. Am J Obstet
delphia, Saunders, 2008, pp 541. DeKoninck P, Appel N, Dixon M, Gundogan Gynecol 2000; 182: 909–912.
19 Walsh MC, Kliegman RM, Fanaroff AA: F: Growth of pulmonary microvasculature 33 Mourani PM, Sontag MK, Younoszai A, Ivy
Necrotizing enterocolitis: a practitioner’s in ventilated preterm infants. Am J Respir DD, Abman SH: Clinical utility of echocar-
perspective. Pediatr Rev 1988; 9: 219–226. Crit Care Med 2006; 173: 204–211. diography for the diagnosis and manage-
26 Nicolini U, Fisk NM, Rodeck CH, Talbert ment of pulmonary vascular disease in
DG, Wigglesworth JS: Low amniotic pres- young children with chronic lung disease.
sure in oligohydramnios – is this the cause of Pediatrics 2008; 121: 317–325.
pulmonary hypoplasia? Am J Obstet Gyne-
col 1989; 161: 1098–1101.
46 Neonatology 2012;101:40–46 Kim /Kim /Choi /Kim /Kim /Choi
Copyright: S. Karger AG, Basel 2011. Reproduced with the permission of S. Karger AG, Basel. Further
reproduction or distribution (electronic or otherwise) is prohibited without permission from the copyright
holder.
